https://news.augustaheadlines.com/story/404792/authors-tranquility-press-presents-over-the-rhine-an-american-story.html 2023-02-03T20:28:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/404791/scabies-market-to-witness-growth-by-20222032-estimates-delveinsight-key-companies-medicines-development-for-global-health-infectopharm-arzneimittel-gmbh-mylan-laboratories.html 2023-02-03T20:24:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/404790/stable-angina-market-is-projected-to-boost-at-a-moderate-growth-rate-by-20222032-evaluated-by-delveinsight-key-companies-tasly-pharmaceuticals-arbor-pharmaceuticals.html 2023-02-03T20:22:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/404789/aplastic-anemia-market-to-exhibit-moderate-growth-rate-till-20222032-investigates-delveinsight-key-companies-regeneron-pharmaceuticals-gamidacell-kyowa-kirin.html 2023-02-03T20:20:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/404788/vasculitis-market-to-exhibit-moderate-growth-rate-till-20222032-investigates-delveinsight-key-companies-novartis-ambulero-inflarx.html 2023-02-03T20:18:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/404787/angelman-syndrome-pipeline-drugs-and-companies-insight-report-2023-analysis-of-clinical-trials-therapies-mechanism-of-action-route-of-administration-and-developments.html 2023-02-03T20:16:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/404786/acute-kidney-injury-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-02-03T20:14:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/404785/ulcerative-colitis-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-02-03T20:12:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/404784/raynauds-disease-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-02-03T20:10:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/404783/amyotrophic-lateral-sclerosis-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight.html 2023-02-03T20:08:02+00:00 daily 1.0